Anatara Lifesciences (ASX:ANR) Other Current Liabilities : A$0.02 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Anatara Lifesciences Other Current Liabilities?

Anatara Lifesciences's other current liabilities for the quarter that ended in Dec. 2023 was A$0.02 Mil.

Anatara Lifesciences's quarterly other current liabilities increased from Dec. 2022 (A$0.02 Mil) to Jun. 2023 (A$0.02 Mil) but then from Jun. 2023 (A$0.02 Mil) to Dec. 2023 (A$0.02 Mil).

Anatara Lifesciences's annual other current liabilities declined from Jun. 2021 (A$0.05 Mil) to Jun. 2022 (A$0.04 Mil) and declined from Jun. 2022 (A$0.04 Mil) to Jun. 2023 (A$0.02 Mil).

Anatara Lifesciences Other Current Liabilities Historical Data

The historical data trend for Anatara Lifesciences's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anatara Lifesciences Other Current Liabilities Chart

Anatara Lifesciences Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Current Liabilities

Get a 7-Day Free Trial

Anatara Lifesciences Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Current Liabilities	Get a 7-Day Free Trial														-	-	-	-	-

Anatara Lifesciences Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Anatara Lifesciences Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Anatara Lifesciences's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Anatara Lifesciences (ASX:ANR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anatara Lifesciences Ltd (ASX:ANR) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/- Perks, 81 Flinders Street, Level 8, Adelaide, SA, AUS, 5000

Website

https://www.anataralifesciences.com

Anatara Lifesciences Ltd is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Its products include the Gastrointestinal ReProgramming dietary supplement (GaRP) for humans and Detach for animals. It generates its income from license revenue.

Anatara Lifesciences (ASX:ANR) Headlines

No Headlines